Ignite Creation Date:
2024-05-05 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00343265
Status:
COMPLETED
Last Update Posted:
2013-08-15
First Post:
2006-06-20
Brief Title:
Vaginal Progesterone Versus Placebo in Multiple Pregnancy
Sponsor:
University of Calgary
Organization:
University of Calgary
Study Overview
Official Title:
Pilot Randomized Trial of Vaginal Progesterone to Prevent Preterm Birth in Multiple Pregnancy
Status:
COMPLETED
Status Verified Date:
2013-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to see if daily use of vaginal progesterone will prevent preterm birth in women carrying 2 or more babies
Detailed Description:
Women who are pregnant with twins or any higher order multiple will be approached to take part Women will be randomized to get either vaginal progesterone gel or a placebo gel daily from study entry until 35 67 weeks Women can enter the study between 16 - 20 67 weeks Two hundred women will be recruited to take part Data will be collected on the women and their infants to see if the active medication prolongs pregnancy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 104425 | None | None | None |
| 9427-U0206-47C | None | None | None |